@Viri_Rios Es la primera vez que escucho a alguien que se encarga de analizar datos de alto nivel tergiversar lo que todos sabemos en el mundo académico de encuestas,lo que miden en popularidad es aceptación emocional y percepción subjetiva,un desatino académico más en pro de la narrativa
@Viri_Rios Hay algo muy preocupante de tu interpretación y es la falta de rigor en tu presentación, algo que nosotros los que si somos científicos de sistemas de salud sabemos, el sesgo de temporalidad lo es todo en la ciencia. Este reporte de datos, la comparación y análisis es incompleto.
Invited commentary on: “Post-surgical ctDNA as a prognostic biomarker for relapse of resected pancreatic ductal adenocarcinoma” https://t.co/JAKvUuff6E
May Issue: Novel Arterial Reconstruction of the Left Gastric Artery Supplying the Replaced Left Hepatic Artery in Distal #Pancreatectomy with Celiac Axis Resection
https://t.co/M5Kq5MEtGv
@DavidCabaMD@SyedAAhmad5@SocSurgOnc
For the past 4yrs we have built a very successful research fellowship,a well rounded 2yr program with high quality research,meaningful clinic experience with support and mentorship. I am very proud and grateful for their trust and their hard work,this was a dream of mine..
@ashdgandhi You’re correct, my bad, followed the link and somehow mixed your name in authors . My confidence in the comments stands based on your quoting it with such certainty and arguing for it..
"The Cutting Edge Of Pancreatic Surgery" Please join us for this lunch Symposium during @SocSurgOnc#SSO2026 Annual meeting with pancreas surgery experts: @Gio_Marchegiani@HoggNDMD Naru Hikoma, Alessandro Panniccia, Katrina Duncan sponsored by @Medtronic
Just landed in Houston 🌵 and the debate at @SocSurgOnc is already on 🔥
💣 #Histotripsy breakthrough or hype?!
👍 Prelim cases good results with no major complications
👎 No RCT on survival it’s still a tool in 🧰
Great discussion 👏 #SSO2026
Just landed in Houston 🌵 and the debate at @SocSurgOnc is already on 🔥
💣 #Histotripsy breakthrough or hype?!
👍 Prelim cases good results with no major complications
👎 No RCT on survival it’s still a tool in 🧰
Great discussion 👏 #SSO2026